FDA Alert: All Sterile Products From Coastal Meds Recalled

An FDA inspection of the drug compounder uncovered visible particulates and poor sterile production practices; company failed to comply with request to inform the public of the recall, prompting FDA’s alert.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply